Pathkey.AI Ltd (PKY.AX)
ASX · AUD · Healthcare · Health Information Services
A$0.018 (+20.00%) as of
Key statistics
- Market cap
- 24.33M
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0132 – 0.0750
- Beta
- 1.53
- Revenue (TTM)
- 47.63k
- Profit margin
- 0.00%
- Analyst target
- A$0.15
- Volume
- 663.17k
About Pathkey.AI Ltd
Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Sydney, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.